Literature DB >> 8765181

Severe acute metabolic acidosis and Wernicke's encephalopathy following chemotherapy with 5-fluorouracil and cisplatin: case report and review of the literature.

K Kondo1, M Fujiwara, M Murase, Y Kodera, S Akiyama, K Ito, H Takagi.   

Abstract

A 28-year-old woman with inoperable gastric carcinoma was given continuous infusion of 5-fluorouracil (5-FU) and low-dose cisplatin (CDDP) for 4 weeks while receiving intravenous hyperalimentation (IVH). Eleven days after her last treatment, she developed acute diplopia, deafness and gait ataxia, followed by severe confusion. She became markedly acidotic and hypotensive with a systolic blood pressure of 60 mmHg, necessitating intubation, dopamine treatment and hemodialysis for 7 h. She was also given thiamine. Thereafter, her blood pressure stabilized, the acidosis improved, and her deafness, diplopia, and confusion were resolved. This case suggests that FP (5-FU/CDDP) therapy toxicity, manifested as acute metabolic acidosis and Wernicke's encephalopathy, may be associated with IVH and thiamine deficiency.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8765181     DOI: 10.1093/oxfordjournals.jjco.a023220

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  17 in total

1.  Antioxidants and Other Micronutrients in Complementary Oncology.

Authors:  Uwe Gröber
Journal:  Breast Care (Basel)       Date:  2009-02-20       Impact factor: 2.860

2.  Wernicke's encephalopathy in advanced gastric cancer.

Authors:  Eun Suk Jung; Obin Kwon; Soo Hyun Lee; Ki Byung Lee; Joo Hoon Kim; Sang Hyun Yoon; Gun Min Kim; Hei-Cheul Jeung; Sun Young Rha
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

3.  Deletion of SLC19A2, the high affinity thiamine transporter, causes selective inner hair cell loss and an auditory neuropathy phenotype.

Authors:  M C Liberman; E Tartaglini; J C Fleming; E J Neufeld
Journal:  J Assoc Res Otolaryngol       Date:  2006-04-27

4.  Wernicke's encephalopathy in a patient with unresectable gastric carcinoma and literature review.

Authors:  Sema Yilmaz Rakici; Sema Dogan Erdemli; Zihni Acar Yazici; Ercument Cengiz; Ozlem Gunay Acar; Gulnihal Tufan
Journal:  Int J Clin Exp Med       Date:  2015-01-15

5.  Hearing loss in Wernicke encephalopathy.

Authors:  Melissa A Walker; Rodrigo Zepeda; Henrietta A Afari; Adam B Cohen
Journal:  Neurol Clin Pract       Date:  2014-12

6.  Successful treatment of Wernicke encephalopathy in terminally ill cancer patients: report of 3 cases and review of the literature.

Authors:  Hideki Onishi; Chiaki Kawanishi; Masanari Onose; Tomoki Yamada; Hideyuki Saito; Akira Yoshida; Kazumasa Noda
Journal:  Support Care Cancer       Date:  2004-05-13       Impact factor: 3.603

7.  Nonalcoholic Thiamine-Related Encephalopathy (Wernicke-Korsakoff Syndrome) Among Inpatients With Cancer: A Series of 18 Cases.

Authors:  Elie Isenberg-Grzeda; Yesne Alici; Vaios Hatzoglou; Christian Nelson; William Breitbart
Journal:  Psychosomatics       Date:  2015-10-23       Impact factor: 2.386

8.  Chemotherapy related encephalopathy in a patient with Stage IV cervical carcinoma treated with cisplatin and 5-fluorouracil: a case report.

Authors:  Amy L Chue; Indrajit N Fernando; Syed A Hussain; David A Yates
Journal:  Cases J       Date:  2009-07-30

9.  A case of Wernicke's encephalopathy following fluorouracil-based chemotherapy.

Authors:  In Jeong Cho; Hye Jung Chang; Kyoung Eun Lee; Hye Sung Won; Moon Young Choi; Eun Mi Nam; Yeung-Chul Mun; Soon Nam Lee; Chu-Myong Seong
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

10.  Association between malignancy and non-alcoholic Wernicke's encephalopathy: a case report and literature review.

Authors:  Evan Y Choi; William A Gomes; Missak Haigentz; Jerome J Graber
Journal:  Neurooncol Pract       Date:  2015-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.